Cargando…

Pharmacophore-based virtual screening, synthesis, biological evaluation, and molecular docking study of novel pyrrolizines bearing urea/thiourea moieties with potential cytotoxicity and CDK inhibitory activities

In the current study, virtual screening of a small library of 1302 pyrrolizines bearing urea/thiourea moieties was performed. The top-scoring hits were synthesised and evaluated for their cytotoxicity against three cancer (MCF-7, A2780, and HT29) and one normal (MRC-5) cell lines. The results of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Shawky, Ahmed M., Ibrahim, Nashwa A., Abourehab, Mohammed A. S., Abdalla, Ashraf N., Gouda, Ahmed M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594867/
https://www.ncbi.nlm.nih.gov/pubmed/33103497
http://dx.doi.org/10.1080/14756366.2020.1837124
_version_ 1783601717100675072
author Shawky, Ahmed M.
Ibrahim, Nashwa A.
Abourehab, Mohammed A. S.
Abdalla, Ashraf N.
Gouda, Ahmed M.
author_facet Shawky, Ahmed M.
Ibrahim, Nashwa A.
Abourehab, Mohammed A. S.
Abdalla, Ashraf N.
Gouda, Ahmed M.
author_sort Shawky, Ahmed M.
collection PubMed
description In the current study, virtual screening of a small library of 1302 pyrrolizines bearing urea/thiourea moieties was performed. The top-scoring hits were synthesised and evaluated for their cytotoxicity against three cancer (MCF-7, A2780, and HT29) and one normal (MRC-5) cell lines. The results of the MTT assay revealed potent cytotoxic activities for most of the new compounds (IC(50) = 0.16–34.13 μM). The drug-likeness study revealed that all the new compounds conform to Lipinski’s rule. Mechanistic studies of compounds 18 b, 19a, and 20a revealed the induction of apoptosis and cell cycle arrest at the G(1) phase in MCF-7 cells. The three compounds also displayed potent inhibitory activity against CDK-2 (IC(50) = 25.53–115.30 nM). Moreover, the docking study revealed a nice fitting of compound 19a into the active sites of CDK-2/6/9. These preliminary results suggested that compound 19a could serve as a promising scaffold in the discovery of new potent anticancer agents.
format Online
Article
Text
id pubmed-7594867
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-75948672020-11-10 Pharmacophore-based virtual screening, synthesis, biological evaluation, and molecular docking study of novel pyrrolizines bearing urea/thiourea moieties with potential cytotoxicity and CDK inhibitory activities Shawky, Ahmed M. Ibrahim, Nashwa A. Abourehab, Mohammed A. S. Abdalla, Ashraf N. Gouda, Ahmed M. J Enzyme Inhib Med Chem Research Paper In the current study, virtual screening of a small library of 1302 pyrrolizines bearing urea/thiourea moieties was performed. The top-scoring hits were synthesised and evaluated for their cytotoxicity against three cancer (MCF-7, A2780, and HT29) and one normal (MRC-5) cell lines. The results of the MTT assay revealed potent cytotoxic activities for most of the new compounds (IC(50) = 0.16–34.13 μM). The drug-likeness study revealed that all the new compounds conform to Lipinski’s rule. Mechanistic studies of compounds 18 b, 19a, and 20a revealed the induction of apoptosis and cell cycle arrest at the G(1) phase in MCF-7 cells. The three compounds also displayed potent inhibitory activity against CDK-2 (IC(50) = 25.53–115.30 nM). Moreover, the docking study revealed a nice fitting of compound 19a into the active sites of CDK-2/6/9. These preliminary results suggested that compound 19a could serve as a promising scaffold in the discovery of new potent anticancer agents. Taylor & Francis 2020-10-26 /pmc/articles/PMC7594867/ /pubmed/33103497 http://dx.doi.org/10.1080/14756366.2020.1837124 Text en © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Paper
Shawky, Ahmed M.
Ibrahim, Nashwa A.
Abourehab, Mohammed A. S.
Abdalla, Ashraf N.
Gouda, Ahmed M.
Pharmacophore-based virtual screening, synthesis, biological evaluation, and molecular docking study of novel pyrrolizines bearing urea/thiourea moieties with potential cytotoxicity and CDK inhibitory activities
title Pharmacophore-based virtual screening, synthesis, biological evaluation, and molecular docking study of novel pyrrolizines bearing urea/thiourea moieties with potential cytotoxicity and CDK inhibitory activities
title_full Pharmacophore-based virtual screening, synthesis, biological evaluation, and molecular docking study of novel pyrrolizines bearing urea/thiourea moieties with potential cytotoxicity and CDK inhibitory activities
title_fullStr Pharmacophore-based virtual screening, synthesis, biological evaluation, and molecular docking study of novel pyrrolizines bearing urea/thiourea moieties with potential cytotoxicity and CDK inhibitory activities
title_full_unstemmed Pharmacophore-based virtual screening, synthesis, biological evaluation, and molecular docking study of novel pyrrolizines bearing urea/thiourea moieties with potential cytotoxicity and CDK inhibitory activities
title_short Pharmacophore-based virtual screening, synthesis, biological evaluation, and molecular docking study of novel pyrrolizines bearing urea/thiourea moieties with potential cytotoxicity and CDK inhibitory activities
title_sort pharmacophore-based virtual screening, synthesis, biological evaluation, and molecular docking study of novel pyrrolizines bearing urea/thiourea moieties with potential cytotoxicity and cdk inhibitory activities
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594867/
https://www.ncbi.nlm.nih.gov/pubmed/33103497
http://dx.doi.org/10.1080/14756366.2020.1837124
work_keys_str_mv AT shawkyahmedm pharmacophorebasedvirtualscreeningsynthesisbiologicalevaluationandmoleculardockingstudyofnovelpyrrolizinesbearingureathioureamoietieswithpotentialcytotoxicityandcdkinhibitoryactivities
AT ibrahimnashwaa pharmacophorebasedvirtualscreeningsynthesisbiologicalevaluationandmoleculardockingstudyofnovelpyrrolizinesbearingureathioureamoietieswithpotentialcytotoxicityandcdkinhibitoryactivities
AT abourehabmohammedas pharmacophorebasedvirtualscreeningsynthesisbiologicalevaluationandmoleculardockingstudyofnovelpyrrolizinesbearingureathioureamoietieswithpotentialcytotoxicityandcdkinhibitoryactivities
AT abdallaashrafn pharmacophorebasedvirtualscreeningsynthesisbiologicalevaluationandmoleculardockingstudyofnovelpyrrolizinesbearingureathioureamoietieswithpotentialcytotoxicityandcdkinhibitoryactivities
AT goudaahmedm pharmacophorebasedvirtualscreeningsynthesisbiologicalevaluationandmoleculardockingstudyofnovelpyrrolizinesbearingureathioureamoietieswithpotentialcytotoxicityandcdkinhibitoryactivities